EUVIMEDEUVIMED entdecken
Crossref

In Silico Development of a Multi-epitope Vaccine Targeting TFDP3: A Novel Approach for Cancer Immunotherapy

Genilda Castro de Omena Neta, Jose Wilson Batista da Silva Junior, Rodger Marcel Lima Rocha, Ana Kelly da Silva Fernandes Duarte, Emisael Stenio Batista Gomes, Fernando Berton Zanchi, Carolinne de Sales Marques, Carlos Alberto de Carvalho Fraga

Cell Biochemistry and Biophysics · 2025

DOI: 10.1007/s12013-025-01830-2 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cell Biochemistry and Biophysics, 2025. Verfasst von Genilda Castro de Omena Neta und 7 weiteren Autor:innen. Beteiligte Einrichtung: Federal University of Alagoas, Arapiraca, Alagoas, Brazil. Hauptthemen laut MEDLINE: Cancer Vaccines, Immunotherapy, Epitopes, Computer Simulation. Die Arbeit nennt 103 Literaturangaben. Gefördert von: Alagoas State Research Support Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The increase in cancer incidence and mortality demonstrates the need for more effective anti-tumor therapies. Targeted therapies, such as cancer testicular antigens (CTAs), are promising as they are expressed in tumor cells but not in normal cells. TFDP3, a CTA expressed in cancers such as triple-negative breast cancer, prostate cancer, childhood T-cell lymphoblastic leukemia, and hepatocellular carcinoma, was chosen as a target for vaccine development. This study aimed to predict a multi-epitope vaccine based on TFDP3 using immunoinformatics tools to identify antigenic epitopes that interact with B lymphocytes, CD4+T lymphocytes, and CD8+T lymphocytes. Three epitopes from each lymphocyte type were selected, considering factors such as antigenicity, allergenicity, toxicity, IFN-γ induction, and population coverage. The vaccine also included adjuvants and ligands that ensure the stability and proper processing of the epitopes. The in-silico analysis revealed that the vaccine has favorable physicochemical properties, low homology with human proteins, and interactions with Toll-like receptors, ensuring stability. The population coverage world of the MHC class I and II epitopes were 93.55%. Additionally, the vaccine can be cloned and induce a robust immune response after three administrations. Despite the promising results, immunotherapy still faces challenges, such as tumor heterogeneity and immune evasion. In vitro and in vivo studies are necessary to assess the vaccine's efficacy and safety for future cancer treatments that express TFDP3.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cancer VaccinesImmunotherapyEpitopesComputer SimulationNeoplasmsAntigens, NeoplasmHumansCD8-Positive T-LymphocytesCD4-Positive T-LymphocytesEpitopes, T-Lymphocyte

Stichwörter der Autor:innen

CancerEpitope predictionImmunoinformaticsPeptide vaccine

Substanzen

Cancer VaccinesEpitopesAntigens, NeoplasmEpitopes, T-Lymphocyte

Autor:innen und Institutionen

  • Federal University of Alagoas, Arapiraca, Alagoas, Brazil.
  • Federal Institute of Alagoas, Satuba, Alagoas, Brazil.
  • Oswaldo Cruz Foundation of Rondonia (FIOCRUZ/RO), Porto Velho, RO, Brazil.
  • Institute of Biological and Health Sciences, Federal University of Alagoas, Maceió, Brazil.
  • Federal University of Alagoas, Arapiraca, Alagoas, Brazil. carlos.fraga@arapiraca.ufal.br.

Förderung

  • Alagoas State Research Support Foundation

Zitieren

APA

de Omena Neta, G. C., da Silva Junior, J. W. B., Rocha, R. M. L., da Silva Fernandes Duarte, A. K., Gomes, E. S. B., Zanchi, F. B., de Sales Marques, C., & de Carvalho Fraga, C. A. (2025). In Silico Development of a Multi-epitope Vaccine Targeting TFDP3: A Novel Approach for Cancer Immunotherapy. Cell Biochemistry and Biophysics. https://doi.org/10.1007/s12013-025-01830-2

Vancouver

de Omena Neta GC, da Silva Junior JWB, Rocha RML, da Silva Fernandes Duarte AK, Gomes ESB, Zanchi FB, et al. In Silico Development of a Multi-epitope Vaccine Targeting TFDP3: A Novel Approach for Cancer Immunotherapy. Cell Biochemistry and Biophysics. 2025. doi:10.1007/s12013-025-01830-2

BibTeX
@article{deOmenaNeta2025,
  author = {de Omena Neta, Genilda Castro and da Silva Junior, Jose Wilson Batista and Rocha, Rodger Marcel Lima and da Silva Fernandes Duarte, Ana Kelly and Gomes, Emisael Stenio Batista and Zanchi, Fernando Berton and de Sales Marques, Carolinne and de Carvalho Fraga, Carlos Alberto},
  title = {In Silico Development of a Multi-epitope Vaccine Targeting TFDP3: A Novel Approach for Cancer Immunotherapy},
  journal = {Cell Biochemistry and Biophysics},
  year = {2025},
  doi = {10.1007/s12013-025-01830-2}
}
Kostenlos starten →